Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03460236 · ClinicalTrials.gov registry record
Precision Assessment of Platelet Rich Plasma for Joint Preservation
A clinical trial, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 90
- Enrollment target
NCT03460236: Completed study, sponsored by VA Office of Research and Development.
NCT03460236 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03460236 has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
Knee Osteoarthritis (OA) is a leading cause of premature disability in Veterans who develop knee OA at higher rates and younger ages than the population in general. For those with symptomatic early knee OA, who are years to decades away from meeting clinical indications for knee replacement surgery, knee injections have been a key treatment option. In recent years, platelet rich plasma (PRP) injections have gained increasing attention for improving pain and function in patients with knee OA. Basic science studies also suggest that PRP may also potentially stimulate repair responses to articular cartilage. However, the mechanisms of action of PRP in the treatment of knee OA are unknown. Because autologous blood is used, the PRP composition differs between patients. It is also unknown whether these differences in PRP composition affect clinical outcomes. This study will address these gaps and provide critical new and objective information on PRP treatment effects in Veterans and additional women with early knee OA important to improving clinical use of this new treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2018-04-02 |
| Est. Completion | 2024-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03460236
The ClinicalTrials.gov registry entry for NCT03460236 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03460236 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03460236 about?
NCT03460236 is a clinical study titled "Precision Assessment of Platelet Rich Plasma for Joint Preservation". Knee Osteoarthritis (OA) is a leading cause of premature disability in Veterans who develop knee OA at higher rates and younger ages than the population in general. For those with symptomatic early knee OA, who are years to decades away from meeting clinical indications for knee replacement surgery,...
What is the current status of trial NCT03460236?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2018-04-02. Estimated completion is 2024-03-31.
Who is sponsoring clinical trial NCT03460236?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.